Commercial kits for yeast identification: Concerns for standardisation

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 20, Issue 5, 2001, Pages 366-367

  Freydiere A M ^a   Odds, F C ^b  

^a Hopital de l'Antiquaille   (France)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL ENZYME;

ACCURACY; CONTROLLED STUDY; DEMOGRAPHY; ENZYME ACTIVITY; FUNGUS IDENTIFICATION; INCUBATION TIME; LETTER; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STANDARDIZATION; TEMPERATURE DEPENDENCE; VALIDATION PROCESS; VIRULENCE; YEAST;

EID: 0034749127     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960100502     Document Type: Letter

References (15)

1. Is a kit for identification of clinical yeasts correctly evaluated when released onto the market?
2. Evaluation of six commercial systems for identification of medically important yeasts
3. Evaluation of the ATB 32C, automicrobic system and API 20C using clinical yeast isolates
4. Auxacolor, a new commercial system for yeast identification: Evaluation of 182 strains comparatively with ID32C
5. Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species
6. Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species
7. Efficacy of API20C and ID 32C systems for identification of common and rare clinical yeast isolates
8. Ability of rapid yeast plus system to identify 304 clinically significant yeasts within 5 hours
9. Comparison of the Rapid Yeast Plus panel with the API20C yeast system for identification of clinically significant isolates of Candida species
10. Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory
11. Comparison of Rapid Yeast Plus system with API 20C system for identification of common, new, and emerging yeast pathogens
12. Peptones and mycological reproducibility
13. Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host
14. Comparative performance of the RapID Yeast Plus system and the API 20C AUX clinical yeast system
15. Evaluating biochemical identification systems